Kardigan, Inc.
NASDAQ:KARDBiotechnology
+$0.77 today
- Market cap
- $1.10B
- Beta
- 0.00
Volume 0.55M
Average 5.84M
KARD Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Operating Income history
Currency unavailable · from the income statement
No Operating Income data reported for this period type.
Operating Income vs competitors
How KARD compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$55.59M USD | -44.8% | — | — | |
| FY2025 | -$76.81M USD | — | — | 412.6% | |
| LTM Mar 2026 | -$85.86M USD | +21.8% | — | 38159.1% | |
| LTM Jun 2026 | -$244.41M USD | -41.4% | — | 3432.2% | |
| LTM Jun 2026 | -$704.62M USD | -28.8% | — | 993.0% | |
| — | — | — | — | — | |
| Peer median (excluding KARD) | — | -35.1% | — | 2212.6% | |
Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Kardigan, Inc.
NASDAQ:KARD
Intrinsic Alpha fair value
Locked
Current Price
$12.32
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.